Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
Cancer 2021 Dec 01;127(23)4421-4431, HM Kantarjian, KH Begna, JK Altman, SL Goldberg, MA Sekeres, SA Strickland, ML Arellano, DF Claxton, MR Baer, M Gautier, E Berman, K Seiter, SR Solomon, GJ Schiller, SM Luger, A Butrym, G Gaidano, XG Thomas, P Montesinos, DA Rizzieri, DP Quick, P Venugopal, R Gaur, LJ Maness, TM Kadia, F Ravandi, ME Buyse, JH ChiaoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.